Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non-cash Items (2024 - 2025)

Harmony Biosciences Holdings' Non-cash Items history spans 2 years, with the latest figure at $52.0 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 1075.26% year-over-year to $52.0 million; the TTM value through Dec 2025 reached $52.0 million, up 1075.26%, while the annual FY2025 figure was $52.0 million, 1075.26% up from the prior year.
  • Non-cash Items for Q4 2025 was $52.0 million at Harmony Biosciences Holdings, up from $5.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $72.8 million in Q3 2024 and bottomed at $3.8 million in Q2 2024.